{"content":"<li class=\"n-box-item date-title\" data-end=\"1498103999\" data-start=\"1498017600\" data-txt=\"Monday, December 23, 2019\">Wednesday, June 21, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3274928\" data-ts=\"1498091645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLS\" target=\"_blank\">SPLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274928-reuters-sycamore-partners-near-deal-to-acquire-staples\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Sycamore Partners near deal to acquire Staples</a></h4><ul>     <li>Staples (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLS' title='Staples, Inc.'>SPLS</a>)&nbsp;<font color='green'>+4.8%</font>&nbsp;AH following a Reuters report that P-E firm Sycamore Partners is <a href=\"http://www.reuters.com/article/us-staples-m-a-sycamorepartners-exclusiv-idUSKBN19C35E?il=0\" target=\"_blank\">in advanced talks to acquire the company</a> in a deal that could top $6B.</li>     <li>Sycamore is in the process of finalizing a debt financing package after it outbid another P-E firm, Cerberus Capital Management, according to the report.</li>     <li>Private-equity acquisitions of retailers have become increasingly rare as the industry struggles, but Sycamore has been more bullish on the sector with prior investments such as department store operator Belk, discount general merchandise retailer Dollar Express and mall and web-based specialty retailer Hot Topic.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274928\" data-linked=\"Reuters: Sycamore Partners near deal to acquire Staples\" data-tweet=\"$SPLS - Reuters: Sycamore Partners near deal to acquire Staples https://seekingalpha.com/news/3274928-reuters-sycamore-partners-near-deal-to-acquire-staples?source=tweet\" data-url=\"https://seekingalpha.com/news/3274928-reuters-sycamore-partners-near-deal-to-acquire-staples\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274915\" data-ts=\"1498080937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274915-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='green'>+9.6%</font>. <a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a> <font color='green'>+4.0%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+4.0%</font>. <a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a> <font color='green'>+3.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a> <font color='red'>-18.1%</font>. <a href='https://seekingalpha.com/symbol/JCAP' title='Jernigan Capital'>JCAP</a> <font color='red'>-7.8%</font>. <a href='https://seekingalpha.com/symbol/NFX' title='Newfield Exploration Co.'>NFX</a> <font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='red'>-2.8%</font>. <a href='https://seekingalpha.com/symbol/TMHC' title='Taylor Morrison'>TMHC</a> <font color='red'>-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274915\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ORCL $APOG $ZN - After Hours Gainers / Losers https://seekingalpha.com/news/3274915-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3274915-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274909\" data-ts=\"1498079770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274909-new-residentialplus-2_9-after-boosting-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Residential +2.9% after boosting dividend</a></h4><ul><li>New Residential (NYSE:<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a>) shorts were feeling good about things after a Tuesday <a href=\"https://seekingalpha.com/news/3274463-new-residential-1-percent-wedbush-downgrade\" target=\"_blank\">morning downgrade</a> sent the stock from nearly $17 to almost $16.</li><li>But shares are&nbsp;<font color='green'>up 2.9%</font>&nbsp;to $16.49 in busy after hours action following <a href=\"https://seekingalpha.com/news/3274890-new-residential-investment-declares-0_50-dividend\" target=\"_blank\">a 4.2% boost in</a> the quarterly dividend to $0.50 per share. Annualized, that's a 12.5% yield based on today's close. It's the 2nd dividend hike this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274909\" data-linked=\"New Residential +2.9% after boosting dividend\" data-tweet=\"$NRZ - New Residential +2.9% after boosting dividend https://seekingalpha.com/news/3274909-new-residentialplus-2_9-after-boosting-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3274909-new-residentialplus-2_9-after-boosting-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274889\" data-ts=\"1498077178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CACI\" target=\"_blank\">CACI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274889-caci-issues-fy18-guidance-sharesminus-2_4-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CACI issues FY18 guidance; shares -2.4% AH</a></h4><ul>     <li>CACI International (NYSE:<a href='https://seekingalpha.com/symbol/CACI' title='CACI International Inc'>CACI</a>) reports FY18 revenue guidance at $4.35B - $4.5B vs. consensus est. of $4.44B.</li>     <li>Gross margin 32% - 33%. D&amp;A ~$75M. Net interest expense ~$45M. Operating cash flow more than $280M. Capex ~35M - 40M.</li>     <li>FY18 net income of $165M - $173M resulting in EPS of $6.52 - $6.84 vs. estimate of $6.83 on estimated 25.3M diluted shares.</li>     <li>The company reiterated FY17 guidance.</li><li>Shares&nbsp;<font color='red'>-2.4% AH</font></li><li><a href=\"https://seekingalpha.com/pr/16868786-caci-issues-guidance-fiscal-year-2018\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3274889\" data-linked=\"CACI issues FY18 guidance; shares -2.4% AH\" data-tweet=\"$CACI - CACI issues FY18 guidance; shares -2.4% AH https://seekingalpha.com/news/3274889-caci-issues-fy18-guidance-sharesminus-2_4-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/3274889-caci-issues-fy18-guidance-sharesminus-2_4-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274888\" data-ts=\"1498077064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CO\" target=\"_blank\">CO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274888-china-cord-blood-fq4-top-line-up-29-earnings-up-362-cash-flow-up-44-shares-up-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Cord Blood FQ4 top line up 29%, earnings up 362%; cash flow up 44%; shares up 3% after hours</a></h4><ul><li>China Cord Blood (NYSE:<a href='https://seekingalpha.com/symbol/CO' title='Global Cord Blood Corporation'>CO</a>) <a href=\"https://seekingalpha.com/pr/16868792-china-cord-blood-corporation-reports-financial-results-fourth-quarter-full-year-fiscal-2017\" target=\"_blank\">fiscal Q4 result</a>s (RMB millions): Revenues: 202.0 (+28.8%); Net Income: 37.9 (+362.2%); CF Ops: 200.5 (+44.3%).</li><li>Revenue from processing fees increased 40% to RMB130.2 million (US$18.9M).</li><li>Almost 75K (+19.1%) subscribers added in fiscal 2017, 20,566 (+42.1%) in FQ4.</li><li>Management will host a conference call tomorrow at 8:00 am ET to review the results.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;after hours but only on 500 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274888\" data-linked=\"China Cord Blood FQ4 top line up 29%, earnings up 362%; cash flow up 44%; shares up 3% after hours\" data-tweet=\"$CO - China Cord Blood FQ4 top line up 29%, earnings up 362%; cash flow up 44%; shares up 3% after hours https://seekingalpha.com/news/3274888-china-cord-blood-fq4-top-line-up-29-earnings-up-362-cash-flow-up-44-shares-up-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3274888-china-cord-blood-fq4-top-line-up-29-earnings-up-362-cash-flow-up-44-shares-up-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274887\" data-ts=\"1498076872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274887-oracle-saas-q4-sales-up-75-expects-fy18-arr-rev-over-2b-up-7_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle SaaS Q4 sales up 75%, expects FY18 ARR rev over $2B; up 7.9%</a></h4><ul><li>Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) reports Q4 results and beats on EPS and revenue estimates.</li><li>SaaS cloud sales were up 75% on the year to $1B. Cloud PaaS and IaaS revenues were $403M, up 42%. Total cloud revenues added up to $1.4B, up 64%, while cloud plus on-premise software revs grew a slight 6% to $8.9B.</li><li>Short-term deferred revenues: $8.2B (+8%).</li><li>Operating margin was up 6% to 46%. OCF TTM was $14.1B, up 3%. Oracle ends FY17 with $21.8B in cash and equivalents.</li><li>Dividend: $0.19 per share paid to stockholders of record on July 19 with the payout on August 2.</li><li>CEO Mark Hurd expects to sell &ldquo;a lot more than $2B in new cloud ARR&rdquo; in the next fiscal year after surpassing this year&rsquo;s goal.</li><li><a href=\"https://seekingalpha.com/pr/16868755-q4-fy17-gaap-eps-15-percent-0_76-non-gaap-eps-10-percent-0_89\" target=\"_blank\">               Press release&nbsp;</a></li><li>Oracle shares are&nbsp;<font color='green'>up 7.86%</font>&nbsp;aftermarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274877-oracle-beats-0_11-beats-revenue\" target=\"_blank\">Oracle beats by $0.11, beats on revenue</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274887\" data-linked=\"Oracle SaaS Q4 sales up 75%, expects FY18 ARR rev over $2B; up 7.9%\" data-tweet=\"$ORCL - Oracle SaaS Q4 sales up 75%, expects FY18 ARR rev over $2B; up 7.9% https://seekingalpha.com/news/3274887-oracle-saas-q4-sales-up-75-expects-fy18-arr-rev-over-2b-up-7_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3274887-oracle-saas-q4-sales-up-75-expects-fy18-arr-rev-over-2b-up-7_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274885\" data-ts=\"1498076329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPRX\" target=\"_blank\">FPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274885-five-prime-chief-williams-to-transition-to-executive-chairman-shares-ease-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Prime chief Williams to transition to Executive Chairman; shares ease 1% after hours</a></h4><ul><li>Five Prime Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a>) founder and CEO Rusty Williams, M.D., Ph.D. plans to <a href=\"https://seekingalpha.com/pr/16868771-five-prime-therapeutics-announces-lewis-t-rusty-williams-plans-transition-ceo-executive\" target=\"_blank\">transition </a>to the role of Executive Chairman next year. The board has initiated a search for a successor.</li><li>Dr. Williams founded the company in late 2001 and has served on the board since January 2002.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274885\" data-linked=\"Five Prime chief Williams to transition to Executive Chairman; shares ease 1% after hours\" data-tweet=\"$FPRX - Five Prime chief Williams to transition to Executive Chairman; shares ease 1% after hours https://seekingalpha.com/news/3274885-five-prime-chief-williams-to-transition-to-executive-chairman-shares-ease-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3274885-five-prime-chief-williams-to-transition-to-executive-chairman-shares-ease-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274883\" data-ts=\"1498075982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OVAS-OLD\" target=\"_blank\">OVAS-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274883-new-chief-ovascience-50-of-jobs-cut-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New chief at OvaScience; 50% of jobs cut; shares down 3% after hours</a></h4><ul><li>OvaScience (NASDAQ:<a href='https://seekingalpha.com/symbol/OVAS-OLD' title='OvaScience, Inc.'>OVAS-OLD</a>) <a href=\"https://seekingalpha.com/pr/16868757-ovascience-appoints-christopher-kroeger-m-d-m-b-chief-executive-officer\" target=\"_blank\">appoints </a>Christopher Kroeger, M.D., MBA, as CEO effective September 1 replacing Michelle Dipp, M.D., Ph.D., will transition to an advisory role. He joins the firm from Cardioxyl Pharmaceuticals where he was CEO.</li><li>Concurrently, the company will reduce its workforce by ~50% which will enable it to extend its cash runway into Q1 2020. Also, CFO Christophe Couturier will step down, succeeded by VP of Finance Jonathan Gillis.</li><li>2017 guidance update: cash consumption from operations will be lower than planned. Current resources should be sufficient to fund operations into Q1 2020.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274883\" data-linked=\"New chief at OvaScience; 50% of jobs cut; shares down 3% after hours\" data-tweet=\"$OVAS-OLD - New chief at OvaScience; 50% of jobs cut; shares down 3% after hours https://seekingalpha.com/news/3274883-new-chief-ovascience-50-of-jobs-cut-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3274883-new-chief-ovascience-50-of-jobs-cut-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274877\" data-ts=\"1498075340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274877-oracle-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle beats by $0.11, beats on revenue</a></h4><ul><li>Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>): Q4 EPS of $0.89 <font color='green'>beats by $0.11</font>.</li><li>Revenue of $10.9B (+2.8% Y/Y) <font color='green'>beats by $450M</font>.</li><li>Shares <font color='green'>+2.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16868755-q4-fy17-gaap-eps-15-percent-0_76-non-gaap-eps-10-percent-0_89'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274877\" data-linked=\"Oracle beats by $0.11, beats on revenue\" data-tweet=\"$ORCL - Oracle beats by $0.11, beats on revenue https://seekingalpha.com/news/3274877-oracle-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3274877-oracle-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274872\" data-ts=\"1498074638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274872-redstone-judge-reverses-allowing-subpoenas-of-cbs-viacom-moonves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Redstone judge reverses, allowing subpoenas of CBS, Viacom, Moonves</a></h4><ul>   <li>A legal drama that had died down (from a corporate standpoint) is <a href=\"http://www.hollywoodreporter.com/thr-esq/leslie-moonves-might-escape-subpoena-sumner-redstone-legal-fight-but-cbs-viacom-wont-1015444\" target=\"_blank\">about to heat up again</a> for CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='green'>+3%</font>) and Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+0.9%</font>).</li>    <li>A change in direction from a California judge overseeing litigation around mogul Sumner Redstone means that the two companies and CBS Chairman Les Moonves will be subpoenaed, meaning business activities may come to light.</li>    <li>Redstone, 93, is suing two former companions (Sydney Holland and Manuela Herzer) for elder abuse, looking to reclaim millions of dollars' worth of gifts. Those two are suing Sumner's daughter Shari Redstone for interfering with their inheritances.</li>    <li>Holland is seeking to subpoena the two companies and Moonves, seeking documents including communications about Redstone's relationships (particularly Moonves' knowledge about other women with which Sumner Redstone had relationships).</li>    <li>The judge is granting those subpoenas as related to the period between Jan. 1, 2010, and June 30, 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274872\" data-linked=\"Redstone judge reverses, allowing subpoenas of CBS, Viacom, Moonves\" data-tweet=\"$VIA $VIA $VIAB - Redstone judge reverses, allowing subpoenas of CBS, Viacom, Moonves https://seekingalpha.com/news/3274872-redstone-judge-reverses-allowing-subpoenas-of-cbs-viacom-moonves?source=tweet\" data-url=\"https://seekingalpha.com/news/3274872-redstone-judge-reverses-allowing-subpoenas-of-cbs-viacom-moonves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274868\" data-ts=\"1498074386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTOO\" target=\"_blank\">TTOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274868-biotech-party-picks-up-t2-biosystems-shares-ahead-28\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotech party picks up T2 Biosystems; shares ahead 28%</a></h4><ul><li>The surge in buying in biotech lifts T2 Biosystems (<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='green'>+28.4%</font>). The stock started to ramp mid-session and now sits at the intraday high on triple normal volume, albeit on turnover of only 330K shares.</li><li>Yesterday, Chief Scientific Officer Tom Lowery, Ph.D., gave a <a href=\"https://seekingalpha.com/pr/16865019-t2-biosystems-chief-scientific-officer-tom-lowery-present-bio-2017-convention\" target=\"_blank\">presentation </a>at the 2017 BIO International Convention in San Diego focused on the key role diagnostic technologies play in improving patient care and decrease the use of antimicrobials.</li><li>The company plans to launch its <a href=\"http://www.t2biosystems.com/t2sepsis-solution/t2bacteria-panel/\" target=\"_blank\">T2Bacteria Panel</a> in Q4.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3234043-t2-biosystems-reports-preliminary-q4-results-operational-progress\" target=\"_blank\">T2 Biosystems reports preliminary Q4 results and operational progress</a> (Jan. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274868\" data-linked=\"Biotech party picks up T2 Biosystems; shares ahead 28%\" data-tweet=\"$TTOO - Biotech party picks up T2 Biosystems; shares ahead 28% https://seekingalpha.com/news/3274868-biotech-party-picks-up-t2-biosystems-shares-ahead-28?source=tweet\" data-url=\"https://seekingalpha.com/news/3274868-biotech-party-picks-up-t2-biosystems-shares-ahead-28\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274867\" data-ts=\"1498073881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APA\" target=\"_blank\">APA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274867-downgrade-palooza-seaport-cutting-50-plus-energy-related-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It&#39;s downgrade-palooza at Seaport, cutting 50-plus energy-related stocks</a></h4><ul>     <li>Seaport Global Securities <a href=\"http://www.barrons.com/articles/oil-bear-ish-well-show-you-bearish-1498056714\" target=\"_blank\">downgrades no fewer than 51 energy-related stocks</a>, warning that $40/bbl oil will keep supply/demand balances in check compared to its previous assumption of $50/bbl oil.</li>     <li>The firm thinks the industry&rsquo;s current trajectory, if left unchecked, will result in an oil market that is as much as 2.2M bbl/day oversupplied in 2018 and only getting worse through 2020.</li><li>\"Something has to give, and first and foremost we think it&rsquo;s further downside to the price of crude,\"&nbsp;Seaport analysts say, envisioning oil revisiting the $20s early next year and averaging $35/bbl in H1 2018.</li><li>Downgraded to Sell: <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a>, <a href='https://seekingalpha.com/symbol/AREX' title='Approach Resources Inc.'>AREX</a>, BBG, <a href='https://seekingalpha.com/symbol/CIR' title='CIRCOR International, Inc.'>CIR</a>, <a href='https://seekingalpha.com/symbol/CLR' title='Continental Resources, Inc.'>CLR</a>, <a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a>, <a href='https://seekingalpha.com/symbol/EGN' title='Energen Corporation'>EGN</a>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a>, <a href='https://seekingalpha.com/symbol/FI' title='Frank&#39;s International'>FI</a>, <a href='https://seekingalpha.com/symbol/HP' title='Helmerich & Payne Inc.'>HP</a>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a>, <a href='https://seekingalpha.com/symbol/NFX' title='Newfield Exploration Co.'>NFX</a>, <a href='https://seekingalpha.com/symbol/OII' title='Oceaneering International Inc.'>OII</a>, <a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a>, <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a>, <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a>, <a href='https://seekingalpha.com/symbol/WPX' title='WPX Energy, Inc.'>WPX</a>, <a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a></li><li>Cut to Neutral: <a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a>, <a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a>, BHI, <a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Co.'>CPE</a>, <a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a>, <a href='https://seekingalpha.com/symbol/DOV' title='Dover Corp'>DOV</a>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a>, <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a>, <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a>, <a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a>, <a href='https://seekingalpha.com/symbol/FTI' title='TechnipFMC plc'>FTI</a>, <a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a>, <a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a>, <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a>, <a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a> <a href='https://seekingalpha.com/symbol/LONE' title='Lonestar Resources US Inc.'>LONE</a>, <a href='https://seekingalpha.com/symbol/LPI' title='Laredo Petroleum Holdings, Inc.'>LPI</a>, <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a>, <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a>, <a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a>, <a href='https://seekingalpha.com/symbol/PDCE' title='PDC Energy, Inc.'>PDCE</a>, <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a>, <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a>, <a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a>, <a href='https://seekingalpha.com/symbol/RES' title='RPC Inc.'>RES</a>, <a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a>, <a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a>, <a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy Australia'>SNDE</a>, <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>, <a href='https://seekingalpha.com/symbol/TWIN' title='Twin Disc, Incorporated'>TWIN</a>, <a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274867\" data-linked=\"It&#39;s downgrade-palooza at Seaport, cutting 50-plus energy-related stocks\" data-tweet=\"$APA $APA $AREX - It&#39;s downgrade-palooza at Seaport, cutting 50-plus energy-related stocks https://seekingalpha.com/news/3274867-downgrade-palooza-seaport-cutting-50-plus-energy-related-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3274867-downgrade-palooza-seaport-cutting-50-plus-energy-related-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274866\" data-ts=\"1498073866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274866-executives-head-to-white-house-for-telecom-issues-summit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Executives head to White House for telecom issues summit</a></h4><ul>   <li>Executives from top telecom companies along with venture capital firms are headed to the White House tomorrow to speak with President Trump about issues including <a href=\"http://www.fiercewireless.com/wireless/at-t-verizon-t-mobile-sprint-execs-to-meet-trump-5g-report\" target=\"_blank\">5G, universal broadband and drones</a>.</li>    <li>The big four U.S. wireless firms (<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a> <font color='red'>-0.8%</font>, <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-1.2%</font>, <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='red'>-0.5%</font>, <a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='green'>+1.1%</font>) will be represented, with AT&amp;T chief Randall Stephenson and Sprint CEO Marcelo Claure in attendance, Reuters says. CenturyLink (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color='red'>-1.2%</font>) chief Glen Post will be there as well.</li>    <li>Sprint and Ericsson (<a href=\"http://seekingalpha.com/symbol/ERIC\" target=\"_blank\">ERIC</a> <font color='green'>+1.6%</font>) were even set to run a 5G demonstration at the summit, but the plan was scrapped, FierceWireless notes.</li>    <li>Among other policy considerations, the Trump administration is examining a possible broad expansion of drone usage. And in 5G, companies are arguing that they need infrastructure for much faster networks -- and that regulatory hurdles are slowing that development.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274866\" data-linked=\"Executives head to White House for telecom issues summit\" data-tweet=\"$VZ $VZ $T - Executives head to White House for telecom issues summit https://seekingalpha.com/news/3274866-executives-head-to-white-house-for-telecom-issues-summit?source=tweet\" data-url=\"https://seekingalpha.com/news/3274866-executives-head-to-white-house-for-telecom-issues-summit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274859\" data-ts=\"1498071615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274859-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+9%</font>. DRAM <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SEV' title='Sevcon, Inc.'>SEV</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274859\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$CA $MARK $RHT - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3274859-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3274859-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274860\" data-ts=\"1498071596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQNR\" target=\"_blank\">EQNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274860-statoil-gets-norway-s-ok-for-njord-bauge-developments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Statoil gets Norway\u2019s OK for Njord, Bauge developments</a></h4><ul><li>Statoil (STO <font color='red'>-1.9%</font>) says Norwegian authorities <a href=\"http://www.epmag.com/norway-gives-statoils-njord-bauge-green-light-1634596#p=full\" target=\"_blank\">approved its $2.3B plan</a> for the Njord and Bauge developments in the Norwegian Sea.</li><li>STO plans to upgrade the Njord A platform and the Njord Bravo FPSO vessel in an effort to  recover&nbsp;resources remaining on the Njord and Hyme fields., which are  believed to hold ~175M boe.</li><li>Oil has been produced from the Njord Field since 1997, and STO says the  upgrades will enable the field to produce for another 20 years.</li><li>STO is operator for both the Njord and Bauge field, with respective ownership stakes of 20% and 35%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274860\" data-linked=\"Statoil gets Norway\u2019s OK for Njord, Bauge developments\" data-tweet=\"$EQNR - Statoil gets Norway\u2019s OK for Njord, Bauge developments https://seekingalpha.com/news/3274860-statoil-gets-norway-s-ok-for-njord-bauge-developments?source=tweet\" data-url=\"https://seekingalpha.com/news/3274860-statoil-gets-norway-s-ok-for-njord-bauge-developments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274853\" data-ts=\"1498069899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274853-energy-materials-top-gainers-losers-of-2-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:30 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+12%</font>. URRE <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CELP' title='Cypress Energy Partners, L.P.'>CELP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BIOA' title='BioAmber'>OTC:BIOA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='red'>-13%</font>. BBG <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='red'>-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274853\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:30 pm\" data-tweet=\"$ZN $WWR $CELP - Energy/Materials - Top Gainers / Losers as of 2:30 pm https://seekingalpha.com/news/3274853-energy-materials-top-gainers-losers-of-2-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3274853-energy-materials-top-gainers-losers-of-2-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274851\" data-ts=\"1498069524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274851-susquehanna-says-sell-off-in-foot-locker-and-dicks-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna says sell-off in Foot Locker and Dick&#39;s overdone</a></h4><ul><li>Susquehanna calls the sell-off in Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-5.7%</font>) and Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='red'>-5.1%</font>) overdone as the impact from Nike selling on Amazon could end up being less than feared.</li><li>Analyst Sam Poser notes that Nike would likely protect valuable properties such as Brand Jordan and wouldn't overlap with retail store offerings.</li><li>Nike accounts for 8.1% of sales at Foot Locker and 2.9% at Dick's.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274799-nervous-trading-report-nike-selling-amazon\" target=\"_blank\">Nervous trading over report of Nike selling on Amazon</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274851\" data-linked=\"Susquehanna says sell-off in Foot Locker and Dick&#39;s overdone\" data-tweet=\"$FL $FL $DKS - Susquehanna says sell-off in Foot Locker and Dick&#39;s overdone https://seekingalpha.com/news/3274851-susquehanna-says-sell-off-in-foot-locker-and-dicks-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3274851-susquehanna-says-sell-off-in-foot-locker-and-dicks-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274844\" data-ts=\"1498066567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274844-afternoon-plunge-for-oil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Afternoon plunge for oil</a></h4><ul><li>Oil had been hanging around modestly in the green for most of the session, but it's cracked back open in the last couple of hours, now&nbsp;<font color='red'>down nearly 3%</font>&nbsp;to a new low for the year of $42.26 per barrel.</li><li>That in turn is dragging down the energy sector (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-1.7%</font>) once again. The S&amp;P 500 is flat.</li><li>The smallest of cracks are beginning to appear in junk bonds, with <a href='https://seekingalpha.com/symbol/HYG' title='iShares iBoxx $ High Yield Corporate Bond ETF'>HYG</a> and <a href='https://seekingalpha.com/symbol/JNK' title='SPDR Barclays Capital High Yield Bond ETF'>JNK</a> both&nbsp;<font color='red'>down about 0.35%</font>&nbsp;despite declining Treasury rates today.</li><li>Earlier, <a href=\"https://seekingalpha.com/news/3274786-crude-futures-rise-post-inventory-data\" target=\"_blank\">the EIA reported </a>a bullish inventory number, with stocks dropping 400K barrels more than expected.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/PXE' title='PowerShares Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/SOP' title='ProShares UltraShort Oil & Gas Exploration & Production ETF'>SOP</a>, <a href='https://seekingalpha.com/symbol/UOP' title='ProShares Ultra Oil & Gas Exploration & Production ETF'>UOP</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274844\" data-linked=\"Afternoon plunge for oil\" data-tweet=\"$XLE $HYG $JNK - Afternoon plunge for oil https://seekingalpha.com/news/3274844-afternoon-plunge-for-oil?source=tweet\" data-url=\"https://seekingalpha.com/news/3274844-afternoon-plunge-for-oil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>153&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274842\" data-ts=\"1498066454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BUFF\" target=\"_blank\">BUFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274842-blue-buffalo-pet-products-swings-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Buffalo Pet Products swings lower</a></h4><ul> <li>Blue Buffalo Pet Products (NASDAQ:<a href='https://seekingalpha.com/symbol/BUFF' title='Blue Buffalo'>BUFF</a>) is <font color='red'>down 4.18%</font> on a high-volume move being attributed to a new Sell rating from Off Wall Street.</li> <li>Bloomberg reports that Off Wall Street set a price target of $16.75 on BUFF (25% downside) due to concerns on premium dog food competition.</li> <li>Over the last two months, Citi and Susquehanba both issued Buy ratings on the stock.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274842\" data-linked=\"Blue Buffalo Pet Products swings lower\" data-tweet=\"$BUFF - Blue Buffalo Pet Products swings lower https://seekingalpha.com/news/3274842-blue-buffalo-pet-products-swings-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3274842-blue-buffalo-pet-products-swings-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274841\" data-ts=\"1498065833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZLDSF\" target=\"_blank\">ZLDSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274841-morgan-stanley-thinks-zalando-is-well-positioned-to-survive-prime-wardrobe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley thinks Zalando is well-positioned to survive Prime Wardrobe</a></h4><ul> <li>Morgan Stanley thinks Zalando (<a href='https://seekingalpha.com/symbol/ZLDSF' title='ZALANDO SE'>OTC:ZLDSF</a>, <a href='https://seekingalpha.com/symbol/ZLNDY' title='ZALANDO SE ADR'>OTCPK:ZLNDY</a>, <a href='https://seekingalpha.com/symbol/ZNDO' title='Zalando'>ZNDO</a>) has a \"protected position\" in apparel even with Amazon's introduciton of Prime Wardrobe.</li> <li>The firm says Zalandro's strong relationship with brands and \"best in class\" logistics give it an edge. The online seller is also seen having a head start on how to use data for in-season fashion purchases.</li> <li>MS has Zalando rated at Overweight with a price target of &euro;46.</li> <li>Zalando is down 5% in Frankfurt trading since the Amazon Prime Warehouse news broke.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274841\" data-linked=\"Morgan Stanley thinks Zalando is well-positioned to survive Prime Wardrobe\" data-tweet=\"$ZLDSF $ZLDSF $ZLNDY - Morgan Stanley thinks Zalando is well-positioned to survive Prime Wardrobe https://seekingalpha.com/news/3274841-morgan-stanley-thinks-zalando-is-well-positioned-to-survive-prime-wardrobe?source=tweet\" data-url=\"https://seekingalpha.com/news/3274841-morgan-stanley-thinks-zalando-is-well-positioned-to-survive-prime-wardrobe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274929\" data-ts=\"1498065453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274929-also-downgraded-macquarie-bp-chevron-shell-eni-whiting-petroleum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Also downgraded at Macquarie: BP, Chevron, Shell, Eni, Whiting Petroleum</a></h4><ul>     <li>In addition to its big <a href=\"https://seekingalpha.com/news/3274839-chesapeake-minus-6_5-percent-macquarie-cuts-sell-says-ill-equipped-cheaper-oil\" target=\"_blank\">downgrade</a> of Chesapeake, Macquarie also lowered several other oil and gas producers, including BP (<a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='red'>-0.9%</font>) to Underperform, and Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-1.9%</font>), Royal Dutch Shell (<a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color='red'>-1.3%</font>) and Eni (<a href='https://seekingalpha.com/symbol/E' title='ENI S.p.A.'>E</a> <font color='red'>-0.1%</font>) to Neutral as the firm cuts its oil price estimates and says the <a href=\"http://thefly.com/thestreet/realmoney/index.php/BPid2569298/BP-BP-downgraded-to-Underperform-from-Neutral-at-Macquarie\" target=\"_blank\">global majors will slip back into deficits</a> and suffer additional painful cost reductions.</li>     <li>Whiting Petroleum (<a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='red'>-9.3%</font>) is cut to Neutral from Outperform with an $8 price target, citing <a href=\"http://thefly.com/thestreet/realmoney/index.php/WLLid2569228/WLL-Whiting-Petroleum-downgraded-to-Neutral-from-Outperform-at-Macquarie\" target=\"_blank\">increasing liquidity concerns</a> given its 2019 debt maturities which will negatively impact activity and production levels; Macquarie says WLL has limited options to boost its balance sheet despite improving results.</li>     <li>The firm also downgrades Cenovus (<a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-3.5%</font>) to Underperform from Neutral a day after CEO&nbsp;Brian Ferguson's <a href=\"https://seekingalpha.com/news/3274433-cenovus-ceo-ferguson-retire-company-sell-4b-5b-non-core-assets\" target=\"_blank\">retirement</a> announcement, and Canadian peer Encana (<a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a> <font color='red'>-4.2%</font>) to Neutral from Outperform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274929\" data-linked=\"Also downgraded at Macquarie: BP, Chevron, Shell, Eni, Whiting Petroleum\" data-tweet=\"$BP $BP $CVX - Also downgraded at Macquarie: BP, Chevron, Shell, Eni, Whiting Petroleum https://seekingalpha.com/news/3274929-also-downgraded-macquarie-bp-chevron-shell-eni-whiting-petroleum?source=tweet\" data-url=\"https://seekingalpha.com/news/3274929-also-downgraded-macquarie-bp-chevron-shell-eni-whiting-petroleum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274840\" data-ts=\"1498065338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274840-financials-top-5-gainers-losers-of-1-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:15 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc'>DS</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a> <font color='red'>-5%</font>. RAS <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274840\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:15 PM\" data-tweet=\"$DS $IRS $RASF - Financials - Top 5 Gainers / Losers as of 1:15 PM https://seekingalpha.com/news/3274840-financials-top-5-gainers-losers-of-1-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3274840-financials-top-5-gainers-losers-of-1-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274838\" data-ts=\"1498065057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274838-moleculin-bio-says-drug-candidate-wp1234-shows-impressive-ability-to-kill-pancreatic-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin Bio says drug candidate WP1234 shows impressive ability to kill pancreatic cancer cells; shares ahead 33%</a></h4><ul><li>Thinly traded nano cap Moleculin Biotech (<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+33%</font>) jumps on a whopping 86x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/16867818-moleculin-announces-significant-discovery-potential-treat-pancreatic-cancer\" target=\"_blank\">announcement </a>that it has a potential game-changing product to treat pancreatic cancer.</li><li>It says candidate WP1234, a modified version of WP1122, demonstrated a 20- to 50-fold greater ability to kill pancreatic cancer cells than traditional glycolysis inhibitors in preclinical testing.</li><li>Pancreatic cancer cells depend on glycolysis (breakdown of glucose) to survive since they thrive in a reduced oxygen environment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274838\" data-linked=\"Moleculin Bio says drug candidate WP1234 shows impressive ability to kill pancreatic cancer cells; shares ahead 33%\" data-tweet=\"$MBRX - Moleculin Bio says drug candidate WP1234 shows impressive ability to kill pancreatic cancer cells; shares ahead 33% https://seekingalpha.com/news/3274838-moleculin-bio-says-drug-candidate-wp1234-shows-impressive-ability-to-kill-pancreatic-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3274838-moleculin-bio-says-drug-candidate-wp1234-shows-impressive-ability-to-kill-pancreatic-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274839\" data-ts=\"1498064870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274839-chesapeakeminus-6_5-macquarie-cuts-to-sell-says-ill-equipped-for-cheaper-oil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake -6.5% as Macquarie cuts to Sell, says ill equipped for cheaper oil</a></h4><ul><li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-6.6%</font>) plunges amid continued weakness among oil and gas companies and Macquarie's <a href=\"http://www.marketwatch.com/story/chesapeake-energys-stock-sinks-after-macquarie-turns-bearish-2017-06-21\" target=\"_blank\">downgrade</a> of CHK shares to Underperform - the firm's equivalent of a Sell rating - from Neutral with a $3.50 price target, slashed from $6.</li><li>Macquarie's Paul Grigel says the lower  outlook for crude oil prices pressures CHK's fundamentals given the  company's recent efforts to increase its oil exposure over natural gas.</li><li>\"While the company has made strides in repositioning itself, it simply  isn't far enough along to sustainably compete in a lower-for-longer  crude world,\" Grigel writes.</li><li>Even though CHK has been selling assets to pay down its high debt  load, Grigel still estimates a \"material outspend on high  leverage with concerns around liquidity.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3274839\" data-linked=\"Chesapeake -6.5% as Macquarie cuts to Sell, says ill equipped for cheaper oil\" data-tweet=\"$CHK - Chesapeake -6.5% as Macquarie cuts to Sell, says ill equipped for cheaper oil https://seekingalpha.com/news/3274839-chesapeakeminus-6_5-macquarie-cuts-to-sell-says-ill-equipped-for-cheaper-oil?source=tweet\" data-url=\"https://seekingalpha.com/news/3274839-chesapeakeminus-6_5-macquarie-cuts-to-sell-says-ill-equipped-for-cheaper-oil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274834\" data-ts=\"1498064041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORV\" target=\"_blank\">CORV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274834-cardiome-inks-distribution-deal-in-israel-for-antibiotic-xydalba-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardiome inks distribution deal in Israel for antibiotic Xydalba; shares ahead 2%</a></h4><ul><li>An affiliate of Cardiome (CRME <font color='green'>+1.8%</font>) has entered into an exclusive license and distribution <a href=\"https://seekingalpha.com/pr/16867846-cardiome-announces-licensing-agreement-xydalba-dalbavancin-hydrochloride-support-planned\" target=\"_blank\">agreement </a>with Tzamal Medical Ltd. aimed at commercializing antibiotic <a href=\"http://cardiome.com/product/xydalba/\" target=\"_blank\">XYDALBA </a>(dalbavancin hydrochloride) in Israel.</li><li>Under the terms of the deal, Cardiome will receive an upfront payment and commercial- and sales-based milestones. Specific financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274834\" data-linked=\"Cardiome inks distribution deal in Israel for antibiotic Xydalba; shares ahead 2%\" data-tweet=\"$CORV - Cardiome inks distribution deal in Israel for antibiotic Xydalba; shares ahead 2% https://seekingalpha.com/news/3274834-cardiome-inks-distribution-deal-in-israel-for-antibiotic-xydalba-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3274834-cardiome-inks-distribution-deal-in-israel-for-antibiotic-xydalba-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274833\" data-ts=\"1498063459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274833-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+44%</font>. <a href='https://seekingalpha.com/symbol/SKYS' title='Sky Solar Holdings'>SKYS</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/AMCN' title='AirMedia Group Inc'>AMCN</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ALBO' title='Albireo Pharma, Inc.'>ALBO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/KDMN' title='Kadmon Holdings'>KDMN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SEV' title='Sevcon, Inc.'>SEV</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='red'>-13%</font>. BBG <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling'>ICD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CIR' title='CIRCOR International, Inc.'>CIR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MRC' title='MRC Global'>MRC</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274833\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$DCTH $SKYS $ANTE - Midday Gainers / Losers https://seekingalpha.com/news/3274833-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3274833-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274830\" data-ts=\"1498063096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274830-arista-networks-up-1_8-after-initial-itc-ruling-in-favor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arista Networks up 1.8% after initial ITC ruling in its favor</a></h4><ul>   <li>Arista Networks (NYSE:<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>) is seeing a move up, <font color='green'>+1.8%</font>, after noting that an initial determination in its International Trade Commission case against Cisco Systems (<a href=\"http://seekingalpha.com/symbol/CSCO\" target=\"_blank\">CSCO</a> <font color='red'>-0.5%</font>) has <a href=\"https://seekingalpha.com/pr/16868576-administrative-law-judge-endorses-arista-s-redesign-itc-initial-determination\" target=\"_blank\">landed in Arista's favor</a>.</li>    <li>The administrative law judge has found that the sale of redesigned switch products doesn't violate a cease and desist order issued by the ITC with respect to the '537 patent.</li>    <li>That follows rulings at Customers and Border Protection of noninfringement on the '537, '145 and '592 patents.</li>    <li>&ldquo;This is an important step in bringing the '944 Investigation to conclusion and we look forward to the Commission&rsquo;s Final Determination, which is currently scheduled to issue no later than Sept. 20,\" says Arista General Counsel Marc Taxay.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274830\" data-linked=\"Arista Networks up 1.8% after initial ITC ruling in its favor\" data-tweet=\"$ANET $ANET $CSCO - Arista Networks up 1.8% after initial ITC ruling in its favor https://seekingalpha.com/news/3274830-arista-networks-up-1_8-after-initial-itc-ruling-in-favor?source=tweet\" data-url=\"https://seekingalpha.com/news/3274830-arista-networks-up-1_8-after-initial-itc-ruling-in-favor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274823\" data-ts=\"1498062063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLB\" target=\"_blank\">SLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274823-schlumberger-downgraded-weatherford-upgraded-barclays\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schlumberger downgraded, Weatherford upgraded at Barclays</a></h4><ul>     <li>Schlumberger (<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='red'>-1.4%</font>) slumps after Barclays <a href=\"http://www.barrons.com/articles/schlumberger-why-do-you-hate-me-1498060316\" target=\"_blank\">downgrades</a> shares to Equal Weight from Overweight with a $73 price target, slashed from $98, saying SLB has \"the most exposure to the long-cycle barrel\" despite being the most defensive name in a challenged market.</li>     <li>Barclays continues to consider SLB \"the best managed company within oilfield services, with the greatest managerial/operational talent, the deepest distribution and supply chain network, an unmatched technology portfolio, a history of consistently strong execution, and by far the furthest global reach.\"</li><li>Meanwhile, the firm <a href=\"http://thefly.com/thestreet/realmoney/index.php/WFTid2569287/WFT-Weatherford-upgraded-to-Overweight-from-Equal-Weight-at-Barclays\" target=\"_blank\">upgrades</a> Weatherford (<a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color='red'>-6.5%</font>) to Overweight from Equal Weight with a $6 target, saying new CEO Mark McCollum has an opportunity to \"put points on the board fairly quickly\" as he starts to change the culture.</li><li>Barclays believes bulls and bears both have strong arguments on WFT, but the scale is tipped in favor of the bulls at the  current stock price.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3274823\" data-linked=\"Schlumberger downgraded, Weatherford upgraded at Barclays\" data-tweet=\"$SLB $SLB $WFTIQ - Schlumberger downgraded, Weatherford upgraded at Barclays https://seekingalpha.com/news/3274823-schlumberger-downgraded-weatherford-upgraded-barclays?source=tweet\" data-url=\"https://seekingalpha.com/news/3274823-schlumberger-downgraded-weatherford-upgraded-barclays\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274821\" data-ts=\"1498061231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274821-consumer-top-gainers-losers-of-12-05-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:05 pm</a></h4><ul>     <li><b>P</b><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SANW' title='S&W Seed Co'>SANW</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CRESY' title='Cresud S.A.C.I.F. y A.'>CRESY</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274821\" data-linked=\"Consumer - Top Gainers / Losers as of 12:05 pm\" data-tweet=\"$LZB $LFVN $WGO - Consumer - Top Gainers / Losers as of 12:05 pm https://seekingalpha.com/news/3274821-consumer-top-gainers-losers-of-12-05-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3274821-consumer-top-gainers-losers-of-12-05-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274812\" data-ts=\"1498059635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYCC\" target=\"_blank\">MYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274812-clubcorp-expands-minnesota-purchase-drive-shack-gets-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClubCorp expands into Minnesota with purchase; Drive Shack gets a boost</a></h4><ul><li>ClubCorp (<a href='https://seekingalpha.com/symbol/MYCC' title='ClubCorp Holdings, Inc.'>MYCC</a> <font color='green'>+1.1%</font>) this morning <a href=\"https://seekingalpha.com/pr/16867759-clubcorp-announces-5th-acquisition-2017-purchase-medina-golf-and-country-club-medina\" target=\"_blank\">announced the purchase</a> of now-formerly member-owned Medina Gold &amp; Country Club, just west of downtown Minneapolis. Terms were not disclosed.</li><li>It's the fifth acquisition for MYCC this year.</li><li>The company expects to put more than $2.5M into the club over the next two years.</li><li>Perhaps coincidence, but roughed-up golf course operator Drive Shack (<a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc'>DS</a> <font color='green'>+9.6%</font>) is seeing a sizable bounce today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274812\" data-linked=\"ClubCorp expands into Minnesota with purchase; Drive Shack gets a boost\" data-tweet=\"$MYCC $MYCC $DS - ClubCorp expands into Minnesota with purchase; Drive Shack gets a boost https://seekingalpha.com/news/3274812-clubcorp-expands-minnesota-purchase-drive-shack-gets-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3274812-clubcorp-expands-minnesota-purchase-drive-shack-gets-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274811\" data-ts=\"1498059612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNKN\" target=\"_blank\">DNKN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274811-dunkin-brands-swings-lower-execs-present-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dunkin&#39; Brands swings lower as execs present at conference</a></h4><ul>     <li>Dunkin' Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/DNKN' title='Dunkin&#39; Brands'>DNKN</a>) is&nbsp;<font color='red'>down 2.36%</font>&nbsp;after the company concedes that competition from McDonald's and Burger King is cutting into to its afternoon traffic.</li>     <li>Execs say that the Dunkin' Donuts chain will continue to test to-go, delivery and curbside pickup services as it looks to evolve.</li>     <li><a href=\"http://investor.dunkinbrands.com/events.cfm\" target=\"_blank\">Jefferies 2017 Global Consumer Conference webcast</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3274811\" data-linked=\"Dunkin&#39; Brands swings lower as execs present at conference\" data-tweet=\"$DNKN - Dunkin&#39; Brands swings lower as execs present at conference https://seekingalpha.com/news/3274811-dunkin-brands-swings-lower-execs-present-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/3274811-dunkin-brands-swings-lower-execs-present-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274810\" data-ts=\"1498059400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274810-chicago-bridgeminus-7-after-macquarie-cuts-price-target-to-street-low-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chicago Bridge -7% after Macquarie cuts price target to Street-low $10</a></h4><ul>     <li>Chicago Bridge &amp;&nbsp;Iron (<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-7.1%</font>) plunges to 52-week lows after Macquarie analyst Sameer Rathod maintains an Underperform rating and <a href=\"https://www.streetinsider.com/Analyst+Comments/Chicago+Bridge+%26+Iron+%28CBI%29+PT+Lowered+to+%2410+at+Macquarie%2C+Street+Low/13032015.html\" target=\"_blank\">cuts his stock price target to a Wall Street low $10</a> from his earlier $11.50.</li><li>Shares did not get more than a momentary bounce after the analyst <a href=\"http://thefly.com/thestreet/realmoney/index.php/CBIid2569636/CBI-Macquarie-clarifies-on-impact-to-CBI-from-Freeport-project-keeps--target\" target=\"_blank\">issues a correction</a> of his earlier statement that the <a href=\"http://www.freeportlng.com/Project_Status.asp\" target=\"_blank\">Freeport LNG project</a> would be delayed 9-12 months, which he had said would strike a <a href=\"https://twitter.com/thenotablecalls/status/877529957949468672\" target=\"_blank\">critical blow</a> to CBI and result in further cost overruns and further pressure the company's fragile liquidity situation.</li><li>In his update, Rathod says a FERC approval will keep the project on track, but he still believes Freeport LNG's plan for a substantial workforce increase would dramatically reduce profitability and push costs well ahead of CBI's plans.</li>           </ul><div class=\"tiny-share-widget\" data-id=\"3274810\" data-linked=\"Chicago Bridge -7% after Macquarie cuts price target to Street-low $10\" data-tweet=\"$CBI - Chicago Bridge -7% after Macquarie cuts price target to Street-low $10 https://seekingalpha.com/news/3274810-chicago-bridgeminus-7-after-macquarie-cuts-price-target-to-street-low-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3274810-chicago-bridgeminus-7-after-macquarie-cuts-price-target-to-street-low-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274801\" data-ts=\"1498057708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274801-takeover-rumors-de-jour-pfizer-taking-out-bristol-myers-acadia-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takeover rumors de jour: Pfizer taking out Bristol-Myers, ACADIA Pharma</a></h4><ul><li>For investors who enjoy the rumor mill: Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+1%</font>) is mulling a takeout of Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='green'>+0.2%</font>) and ACADIA Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='green'>+3.4%</font>) is in the crosshairs of an unnamed suitor.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274801\" data-linked=\"Takeover rumors de jour: Pfizer taking out Bristol-Myers, ACADIA Pharma\" data-tweet=\"$PFE $PFE $BMY - Takeover rumors de jour: Pfizer taking out Bristol-Myers, ACADIA Pharma https://seekingalpha.com/news/3274801-takeover-rumors-de-jour-pfizer-taking-out-bristol-myers-acadia-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3274801-takeover-rumors-de-jour-pfizer-taking-out-bristol-myers-acadia-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>97&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274799\" data-ts=\"1498057393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274799-nervous-trading-over-report-of-nike-selling-on-amazon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nervous trading over report of Nike selling on Amazon</a></h4><ul><li>Speculation from Goldman Sachs that Nike is close to selling directly on Amazon is taking a wrecking ball to the sporting goods and shoe store sectors.</li><li>Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='red'>-5.5%</font>), Hibbett Sports (<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='red'>-3.4%</font>), Big 5 Sporting Goods (<a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='red'>-4%</font>), Finish Line (<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a> <font color='red'>-1.5%</font>), Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='red'>-5.4%</font>), Shoe Carnival (<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color='red'>-5.2%</font>), Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='red'>-2%</font>) and Genesco (<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a> <font color='red'>-2.2%</font>) are all notably lower.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274712-talk-nike-selling-directly-amazon\" target=\"_blank\">Talk of Nike selling directly on Amazon</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274799\" data-linked=\"Nervous trading over report of Nike selling on Amazon\" data-tweet=\"$DKS $DKS $HIBB - Nervous trading over report of Nike selling on Amazon https://seekingalpha.com/news/3274799-nervous-trading-over-report-of-nike-selling-on-amazon?source=tweet\" data-url=\"https://seekingalpha.com/news/3274799-nervous-trading-over-report-of-nike-selling-on-amazon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274772\" data-ts=\"1498057209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274772-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FLGT' title='Fulgent Genetics'>FLGT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> SKLN <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274772\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$DCTH $IMDZ $CRIS - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3274772-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3274772-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274795\" data-ts=\"1498057171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274795-biotechs-ripping-ibb-up-almost-8-in-three-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechs ripping, IBB up almost 8% in three days</a></h4><ul><li>Money flow into biotech has turned decidedly positive. The iShares Nasdaq Biotechnology ETF (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='green'>+3%</font>) has rallied almost&nbsp;<font color='green'>8%</font>&nbsp;since Friday.</li><li>Key drivers appear to be reduced anxiety over drug prices with the GOP's rebooted healthcare plan and President Trump's expected executive order, looming M&amp;A deals and expectations of bullish Q1 results from Big Biopharma.</li><li>Selected tickers: <a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a> <a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274795\" data-linked=\"Biotechs ripping, IBB up almost 8% in three days\" data-tweet=\"$PFE $IBB $BIB - Biotechs ripping, IBB up almost 8% in three days https://seekingalpha.com/news/3274795-biotechs-ripping-ibb-up-almost-8-in-three-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3274795-biotechs-ripping-ibb-up-almost-8-in-three-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274794\" data-ts=\"1498056498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274794-netflixplus-2-rumor-mill-recharges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix +2% as rumor mill recharges</a></h4><ul><li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) is&nbsp;<font color='green'>up 2.07%</font>&nbsp;amid social media chatter on Warren Buffett taking a stake in the streamer.</li><li>There's nothing concrete about the rumor, nor does it quite add up given the Oracle's track record of investing, but there's no questioning the solid move in Netflix's share price today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274794\" data-linked=\"Netflix +2% as rumor mill recharges\" data-tweet=\"$NFLX - Netflix +2% as rumor mill recharges https://seekingalpha.com/news/3274794-netflixplus-2-rumor-mill-recharges?source=tweet\" data-url=\"https://seekingalpha.com/news/3274794-netflixplus-2-rumor-mill-recharges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274791\" data-ts=\"1498056079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274791-analysts-flock-to-raise-red-hat-targets-after-stellar-earnings-shares-up-over-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts flock to raise Red Hat targets after stellar earnings; shares up over 10%</a></h4><ul><li>           Rosenblatt raises Red Hat (NYSE:<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>) price target to $112 from $95 and maintains Buy rating citing strong deal metrics and higher bookings compared to the prior year&rsquo;s quarter. </li><li>           Bank of America Merrill Lynch raises the target to $105 from $92 and maintains Neutral rating also citing billings strength. Expects muted margin leverage near-term and forecasts FY18 margin at 31%. &nbsp; </li><li>        Others new price targets: Oppenheimer: $105 (was $96); Drexel Hamilton: $127 (was $110); and Morgan Stanley: $98 (from $90).</li><li>               Source: <a href=\"https://www.streetinsider.com/stock_lookup.php?LookUp=Get+Quote&amp;q=RHT\" target=\"_blank\">StreetInsider</a>&nbsp;</li><li>               Red Hat shares are&nbsp;<font color='green'>up 10.16%</font>&nbsp;to $99.10.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274638-red-hat-beats-consensus-earnings-guidance-shares-9_7-percent\" target=\"_blank\">Red Hat beats consensus on earnings, guidance; shares up 9.7%</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274791\" data-linked=\"Analysts flock to raise Red Hat targets after stellar earnings; shares up over 10%\" data-tweet=\"$RHT - Analysts flock to raise Red Hat targets after stellar earnings; shares up over 10% https://seekingalpha.com/news/3274791-analysts-flock-to-raise-red-hat-targets-after-stellar-earnings-shares-up-over-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3274791-analysts-flock-to-raise-red-hat-targets-after-stellar-earnings-shares-up-over-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274790\" data-ts=\"1498055958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWR\" target=\"_blank\">WWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274790-uranium-resources-acquires-third-lithium-exploration-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uranium Resources acquires third lithium exploration project</a></h4><ul>     <li>Uranium Resources (URRE <font color='green'>+6.1%</font>) is higher after <a href=\"http://www.uraniumresources.com/investors/news-releases//2017/06/20/uranium-resources-continues-lithium-business-expansion\" target=\"_blank\">agreeing to acquire</a> a third lithium exploration project, through staking of 9,270 acres of federal placer mining claims in central Nevada's Railroad Valley; terms are not disclosed.</li><li>URRE says the Railroad Valley project covers an area for which company-led reconnaissance  sediment sampling returned lithium values as high as 366 ppm.</li>     <li>URRE says it will integrate the project into its ongoing lithium exploration activities in Nevada and Utah.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274790\" data-linked=\"Uranium Resources acquires third lithium exploration project\" data-tweet=\"$WWR - Uranium Resources acquires third lithium exploration project https://seekingalpha.com/news/3274790-uranium-resources-acquires-third-lithium-exploration-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3274790-uranium-resources-acquires-third-lithium-exploration-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274787\" data-ts=\"1498055518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274787-twitter-up-6-cleveland-research-hearing-good-ad-feedback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter up 6%; Cleveland Research hearing good ad feedback</a></h4><ul>   <li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) is wrapping up its first hour on a roller-coaster-shaped climb, <font color='green'>up 6%</font> on relatively heavy volume and no news in particular.</li>    <li>The stock's at its highest point in three weeks. For 2017, it's up 10.1%.</li>    <li>It is getting a positive note from Cleveland Research, which Bloomberg notes is receiving \"constructive feedback\" from advertisers on Twitter's live-content strategy, the best relative feedback it's gotten in more than two years.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274787\" data-linked=\"Twitter up 6%; Cleveland Research hearing good ad feedback\" data-tweet=\"$TWTR - Twitter up 6%; Cleveland Research hearing good ad feedback https://seekingalpha.com/news/3274787-twitter-up-6-cleveland-research-hearing-good-ad-feedback?source=tweet\" data-url=\"https://seekingalpha.com/news/3274787-twitter-up-6-cleveland-research-hearing-good-ad-feedback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274786\" data-ts=\"1498055444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274786-crude-futures-rise-post-inventory-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude futures rise post inventory data</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>-2.5</strong><strong>M</strong> barrels vs. -2.1M consensus, -1.7M last week.</li>     <li>Gasoline <strong>-0.6</strong><strong>M</strong> barrels vs. +0.4M consensus, +2.1M last week.</li>     <li>Distillates <strong>+1.1M</strong> vs. +0.5M consensus, +0.3M last week.</li>     <li>Futures&nbsp;<font color='green'>+0.51%</font>&nbsp;to $43.73.</li>     <li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3274786\" data-linked=\"Crude futures rise post inventory data\" data-tweet=\"$USO $OIL $UCO - Crude futures rise post inventory data https://seekingalpha.com/news/3274786-crude-futures-rise-post-inventory-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3274786-crude-futures-rise-post-inventory-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274781\" data-ts=\"1498054675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYRX\" target=\"_blank\">CYRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274781-short-attack-on-cyroport-launched\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Short attack on Cyroport launched</a></h4><ul>     <li>Short-selling firm The Street Sweeper just put out a <a href=\"https://thestreetsweeper.org/\" target=\"_blank\">negative report</a> on Cyroport (<a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='red'>-2.2%</font>).</li><li>As is its way, the firm takes a dark stance on the company.</li>     <li>\"Investors who&rsquo;ve taken this cold, dark pathway should be ready to throw Cryoport into one of its sub-zero storage containers. TheStreetSweeper expects a drop of 25% as this stock falls back into a long, deep freeze,\" reads the conclusion to the article.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274781\" data-linked=\"Short attack on Cyroport launched\" data-tweet=\"$CYRX - Short attack on Cyroport launched https://seekingalpha.com/news/3274781-short-attack-on-cyroport-launched?source=tweet\" data-url=\"https://seekingalpha.com/news/3274781-short-attack-on-cyroport-launched\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274777\" data-ts=\"1498053929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOV\" target=\"_blank\">DOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274777-dover-downgraded-seaport-global\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover downgraded at Seaport Global</a></h4><ul><li>The firm <a href=\"https://sportsperspectives.com/2017/06/21/seaport-global-securities-lowers-dover-corporation-dov-to-neutral.html\" target=\"_blank\">lowered</a> Dover (<a href='https://seekingalpha.com/symbol/DOV' title='Dover Corp'>DOV</a> <font color='red'>-2.3%</font>) to Neutral from Buy and cut its price target to $86 from $91 to reflect a new commodity price deck.</li><li>Seaport Global's energy team reduced its long-term oil forecast to $40/bbl from $50 to reflect \"relentless\" U.S. production growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274777\" data-linked=\"Dover downgraded at Seaport Global\" data-tweet=\"$DOV - Dover downgraded at Seaport Global https://seekingalpha.com/news/3274777-dover-downgraded-seaport-global?source=tweet\" data-url=\"https://seekingalpha.com/news/3274777-dover-downgraded-seaport-global\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274770\" data-ts=\"1498053192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274770-leap-therapeutics-to-explore-potential-of-dknminus-01-keytruda-combo-in-treatment-resistant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leap Therapeutics to explore the potential of DKN-01/Keytruda combo in treatment -resistant esophagogastric cancers; shares ahead 5%</a></h4><ul><li>Leap Therapeutics (<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a> <font color='green'>+5.4%</font>) inks a clinical trial <a href=\"https://seekingalpha.com/pr/16868233-leap-therapeutics-announces-collaboration-merck-evaluate-keytruda-pembrolizumab-combination\" target=\"_blank\">collaboration</a> agreement with Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='green'>+0.9%</font>) to investigate the combination of DKN-01 and KEYTRUDA (pembrolizumab) for the treatment of relapsed/refractory advanced esophagogastric cancers.</li><li>Leap VP, Clinical Development Cynthia Sirard, M.D., says, &ldquo;This clinical collaboration with Merck is the first of the combination immunotherapy studies we plan to initiate in each of our two programs, DKN-01 and TRX518. Combining DKN-01 with KEYTRUDA has a strong scientific rationale and offers hope to patients with few treatment options.\"</li><li>Additional terms of the partnership are not disclosed, but Merck is principally just supplying product (at least initially).</li><li><a href=\"http://www.leaptx.com/science/#modulate-wnt-signaling\" target=\"_blank\">DKN-01</a>&nbsp;is a humanized IgG4 monoclonal antibody that binds to&nbsp;<a href=\"https://en.wikipedia.org/wiki/DKK1\" target=\"_blank\">Dickkopf-1</a>&nbsp;(DKK1), a protein associated with a poor prognosis in a range of cancers. Specifically, it inhibits a pathway called canonical Wnt/Beta-catenin which plays a key role in embryonic development, cell proliferation and differentiation.</li><li>Pembrolizumab&nbsp;helps the immune system fight tumor cells by blocking the interaction between&nbsp;<a href=\"https://en.wikipedia.org/wiki/Programmed_cell_death_1\" target=\"_blank\">PD-1</a>, a cell surface receptor expressed on T cells and pro-B cells, and its ligands PD-L1 and PD-L2. PD-1 is an immune checkpoint which down regulates the immune system.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3274770\" data-linked=\"Leap Therapeutics to explore the potential of DKN-01/Keytruda combo in treatment -resistant esophagogastric cancers; shares ahead 5%\" data-tweet=\"$LPTX $LPTX $MRK - Leap Therapeutics to explore the potential of DKN-01/Keytruda combo in treatment -resistant esophagogastric cancers; shares ahead 5% https://seekingalpha.com/news/3274770-leap-therapeutics-to-explore-potential-of-dknminus-01-keytruda-combo-in-treatment-resistant?source=tweet\" data-url=\"https://seekingalpha.com/news/3274770-leap-therapeutics-to-explore-potential-of-dknminus-01-keytruda-combo-in-treatment-resistant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274759\" data-ts=\"1498051173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274759-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a><font color='green'>+13%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16868106-ca-technologies-introduces-microservices-solution-create-manage-modern-application\" target=\"_blank\">announcing</a> new solutions and capabilities&nbsp;&nbsp;to help developers, enterprise architects and digital leaders.</li>     <li><a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>&nbsp;<font color='green'>+10%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3274747-biodelivery-inks-deal-cvs-extending-access-belbuca-bunavail-2020-shares-ahead-10-percent\" target=\"_blank\">agreement&nbsp;</a>with CVS/Caremark (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) extending access to pain meds BELBUCA (buprenorphine) buccal film &#40;CIII&#41; and BUNAVAIL (buprenorphine and naloxone) through 2020.</li>     <li><a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>&nbsp;<font color='green'>+9%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3274609-red-hat-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>&nbsp;<font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16867927-biocept-medincrease-health-plans-announce-provider-agreement-expanding-access-liquid-biopsy\" target=\"_blank\">providing</a> physicians with clinically actionable information to improve the outcomes of cancer patients.</li>     <li><a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a>&nbsp;<font color='green'>+7%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3274710-carmax-beats-0_15-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+7%</font>.</li>     <li>DRAM <font color='green'>+7%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3274759\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$CA $BDSI $CVS - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3274759-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3274759-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274755\" data-ts=\"1498050590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274755-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3274744-sangamo-prices-stock-offering-7_25-shares-12-percent-premarket\" target=\"_blank\">pricing</a> public offering of 10M common shares.</li><li><a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anonima'>YPF</a>&nbsp;<font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3274755\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$SGMO $YPF - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3274755-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3274755-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274747\" data-ts=\"1498049956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274747-biodelivery-inks-deal-cvs-extending-access-to-belbuca-and-bunavail-through-2020-shares-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery inks deal with CVS extending access to Belbuca and Bunavail through 2020; shares ahead 10% premarket</a></h4><ul><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>) inks an <a href=\"https://seekingalpha.com/pr/16868051-biodelivery-sciences-announces-agreement-cvs-caremark-belbuca-bunavail-2020\" target=\"_blank\">agreement </a>with CVS/Caremark (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) extending access to pain meds BELBUCA (buprenorphine) buccal film &#40;CIII&#41; and BUNAVAIL (buprenorphine and naloxone) through 2020.</li><li>Shares are up&nbsp;<font color='green'>10%</font>&nbsp;premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274747\" data-linked=\"BioDelivery inks deal with CVS extending access to Belbuca and Bunavail through 2020; shares ahead 10% premarket\" data-tweet=\"$BDSI $BDSI $CVS - BioDelivery inks deal with CVS extending access to Belbuca and Bunavail through 2020; shares ahead 10% premarket https://seekingalpha.com/news/3274747-biodelivery-inks-deal-cvs-extending-access-to-belbuca-and-bunavail-through-2020-shares-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3274747-biodelivery-inks-deal-cvs-extending-access-to-belbuca-and-bunavail-through-2020-shares-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274746\" data-ts=\"1498049700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274746-carmax-rallies-after-bottom-line-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax rallies after bottom line beat</a></h4><ul> <li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a>) trades higher after the company blasts past the consensus EPS estimate with its FQ1 report.</li> <li>The auto retailer says it benefited from the shift of some tax refund spending into the quarter.</li> <li>Comparable store used units rose 8.2% during the quarter and comparable store revenue was up 6.1%.</li> <li>Net earnings as a percentage of sales improved 50 bps to 4.7% as a lower percentage of SG&amp;A spending factored in.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274710-carmax-beats-0_15-beats-revenue\" target=\"_blank\">CarMax beats by $0.15, beats on revenue</a> (June 21)</li> <li>KMX <font color='green'>+7.58%</font> premarket to $63.75 to almost erase the one-month slump in share price heading into the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274746\" data-linked=\"CarMax rallies after bottom line beat\" data-tweet=\"$KMX - CarMax rallies after bottom line beat https://seekingalpha.com/news/3274746-carmax-rallies-after-bottom-line-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3274746-carmax-rallies-after-bottom-line-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274745\" data-ts=\"1498049682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLNG\" target=\"_blank\">GLNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274745-golar-lng-signs-deal-to-develop-delfin-lng-project-in-louisiana\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Golar LNG signs deal to develop Delfin LNG project in Louisiana</a></h4><ul><li>Golar LNG (NASDAQ:<a href='https://seekingalpha.com/symbol/GLNG' title='Golar LNG Limited'>GLNG</a>)&nbsp;<font color='green'>+7.8%</font>&nbsp;premarket after signing a <a href=\"https://seekingalpha.com/pr/16867836-golar-lng-delfin-midstream-sign-agreement-jointly-develop-delfin-lng-project-us-gulf-mexico\" target=\"_blank\">joint agreement</a> with Delfin Midstream to develop the Delfin LNG project on the Louisiana coast.</li><li>Delfin LNG is the only permitted floating liquefied natural gas export  project in the U.S. and supports up to four FLNG vessels  producing as much as 13M metric tons/month of LNG ; it owns the UTOS pipeline, the largest natural gas pipeline  in the Gulf of Mexico, and submitted its Deepwater Port license application in 2015.</li><li>GLNG expects a final investment decision on the Delfin project will occur in 2018, with first LNG to be delivered in 2021-22.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274745\" data-linked=\"Golar LNG signs deal to develop Delfin LNG project in Louisiana\" data-tweet=\"$GLNG - Golar LNG signs deal to develop Delfin LNG project in Louisiana https://seekingalpha.com/news/3274745-golar-lng-signs-deal-to-develop-delfin-lng-project-in-louisiana?source=tweet\" data-url=\"https://seekingalpha.com/news/3274745-golar-lng-signs-deal-to-develop-delfin-lng-project-in-louisiana\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274744\" data-ts=\"1498049347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274744-sangamo-prices-stock-offering-7_25-shares-down-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo prices stock offering at $7.25; shares down 12% premarket</a></h4><ul><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) <a href=\"https://seekingalpha.com/pr/16867954-sangamo-therapeutics-announces-pricing-72_5-million-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 10M shares of common stock at $7.25 per shares. Underwriters over-allotment is an additional 1.5M shares. Closing date is June 26.</li><li>Net proceeds will fund working capital and general corporate purposes.</li><li>Shares are off&nbsp;<font color='red'>12%</font>&nbsp;premarket on robust volume.</li><li><strong>Update</strong>: The company has shaken off early selling, now up&nbsp;<font color='green'>11%</font>. Jefferies upgraded to Buy this morning with a $17 (109% upside) by Jefferies citing the hedge value of its gene-editing technology based on zinc finger proteins compared to much-hyped CRISPR/Cas9.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274744\" data-linked=\"Sangamo prices stock offering at $7.25; shares down 12% premarket\" data-tweet=\"$SGMO - Sangamo prices stock offering at $7.25; shares down 12% premarket https://seekingalpha.com/news/3274744-sangamo-prices-stock-offering-7_25-shares-down-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3274744-sangamo-prices-stock-offering-7_25-shares-down-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274737\" data-ts=\"1498048312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274737-fda-oks-shires-mydayis-for-adhd-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Shire&#39;s Mydayis for ADHD; shares up 1% premarket</a></h4><ul><li>Shire plc (NASDAQ:<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume after the FDA <a href=\"https://seekingalpha.com/pr/16867536-shire-plc-u-s-fda-approves-mydayis-tm-mixed-salts-single-entity-amphetamine-product-new-daily\" target=\"_blank\">approved</a> MYDAYIS (mixed salts of single-entity amphetamine product) for the treatment of attention deficit/hyperactivity disorder &#40;ADHD&#41; in patients at least 13 years old. Commercial launch in the U.S. will commence next quarter.</li><li>MYDAYIS, formerly SHP465, is designed to control symptoms for up to 16 hours.</li><li>ADHD-related tickers: <a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a> ADHD <a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3274737\" data-linked=\"FDA OKs Shire&#39;s Mydayis for ADHD; shares up 1% premarket\" data-tweet=\"$SHPG $SHPG $NEOS - FDA OKs Shire&#39;s Mydayis for ADHD; shares up 1% premarket https://seekingalpha.com/news/3274737-fda-oks-shires-mydayis-for-adhd-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3274737-fda-oks-shires-mydayis-for-adhd-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274733\" data-ts=\"1498047924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CA\" target=\"_blank\">CA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274733-ca-shares-up-10_8-on-buyout-rumors-analyst-says-make-sense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CA shares up 10.8% on buyout rumors analyst says &quot;make sense&quot;</a></h4><ul><li>        Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2017-06-20/bmc-software-ca-said-to-weigh-deal-to-combine-take-ca-private\" target=\"_blank\">reports</a> early deal talks between BMC and cloud app company CA (NASDAQ:<a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a>) that would take the latter private in a leveraged buyout of a size not seen since the Dell deal in 2013.</li><li>                  Financial details of the potential CA buyout weren&rsquo;t disclosed but the company has a market cap of $13.2B. The similar Dell deal ended up with a $25B transaction value.    </li><li>               Raymond James analyst Dr. Mike Turits <a href=\"https://www.streetinsider.com/Analyst+Comments/Raymond+James+Comments+On+CA+Tech+%28CA%29+Going+Private%2C+%22Makes+Sense%22/13030398.html\" target=\"_blank\">says</a> the deal would &ldquo;make sense&rdquo; as CA has struggled to show organic growth, but the companies in combination could consolidate markets and operations and turn the duo into a &ldquo;cash cow.&rdquo;&nbsp;</li><li>               CA shares are&nbsp;<font color='green'>up 10.83%</font>&nbsp;premarket.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3274733\" data-linked=\"CA shares up 10.8% on buyout rumors analyst says &quot;make sense&quot;\" data-tweet=\"$CA - CA shares up 10.8% on buyout rumors analyst says &quot;make sense&quot; https://seekingalpha.com/news/3274733-ca-shares-up-10_8-on-buyout-rumors-analyst-says-make-sense?source=tweet\" data-url=\"https://seekingalpha.com/news/3274733-ca-shares-up-10_8-on-buyout-rumors-analyst-says-make-sense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274728\" data-ts=\"1498047368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARA\" target=\"_blank\">CARA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274728-caras-late-stage-study-of-iv-cr845-in-abdominal-surgery-to-continue-to-test-two-doses-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cara&#39;s late-stage study of IV CR845 in abdominal surgery to continue to test two doses; shares down 4% premarket</a></h4><ul><li>Investors appear a bit <a href=\"https://seekingalpha.com/pr/16867782-cara-therapeutics-reports-continuation-phase-3-trial-v-cr845-postoperative-pain-following\" target=\"_blank\">disappointed </a>with the results from an interim analysis of a Phase 3 clinical trial assessing Cara Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a>) IV CR845 for the treatment of post-operative pain in patients undergoing abdominal surgery. The Independent Data Monitoring Committee recommended that the study continue to test both doses of CR845. In other words, the study has yet to achieve the primary endpoint. No safety signals were observed.</li><li>The primary outcome measure is the change in pain intensity over the 24-hour period following surgery versus placebo as measured by the patient-reported Numeric Rating Scale &#40;NRS&#41; score.</li><li><a href=\"http://www.caratherapeutics.com/cr845.shtml\" target=\"_blank\">IV CR845</a>, a peripherally acting kappa opioid receptor agonist, is being developed for the treatment of acute and chronic pain. Its value proposition is opioid-like analgesia without the respiratory depression or intestinal tract inhibition (constipation).</li><li>Shares are down&nbsp;<font color='red'>4%</font>&nbsp;premarket on average volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3174333-fda-lifts-clinical-hold-caras-late-stage-study-iv-cr845-trial-continue-lower-doses-shares-6\" target=\"_blank\">FDA lifts clinical hold on Cara's late-stage study of IV CR845, trial to continue at lower doses; shares off 6%</a> (April 20, 2016)</li><li><strong>Update</strong>: The stock shrugs off early selling and is now up&nbsp;<font color='green'>10%&nbsp;</font>on a 72% surge in volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274728\" data-linked=\"Cara&#39;s late-stage study of IV CR845 in abdominal surgery to continue to test two doses; shares down 4% premarket\" data-tweet=\"$CARA - Cara&#39;s late-stage study of IV CR845 in abdominal surgery to continue to test two doses; shares down 4% premarket https://seekingalpha.com/news/3274728-caras-late-stage-study-of-iv-cr845-in-abdominal-surgery-to-continue-to-test-two-doses-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3274728-caras-late-stage-study-of-iv-cr845-in-abdominal-surgery-to-continue-to-test-two-doses-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274720\" data-ts=\"1498046349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXB\" target=\"_blank\">FXB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274720-boes-chief-economist-turns-hawkish-pound-on-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BOE&#39;s chief economist turns hawkish; pound on the rise</a></h4><ul><li>The Bank of England's Andy Haldane says he's leaning towards joining the ranks of those on the MPC voting for a rate hike.</li><li>\"The risks of tightening &lsquo;too early&rsquo; have shrunk as growth and, to lesser extent, inflation have shown greater resilience than expected,&rdquo; <a href=\"http://www.bankofengland.co.uk/publications/Pages/speeches/2017/984.aspx\" target=\"_blank\">he says in a speech</a>. \"The process of withdrawing some of the incremental stimulus provided last August would be prudent moving into the second half of the year.&rdquo;</li><li>Haldane's hawkish thoughts are particularly notable given his dovish reputation.</li><li>The pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='Invesco CurrencyShares British Pound Sterling Trust ETF'>FXB</a>) is&nbsp;<font color='green'>higher by 0.5%</font>&nbsp;vs. the dollar to $1.2689.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274720\" data-linked=\"BOE&#39;s chief economist turns hawkish; pound on the rise\" data-tweet=\"$FXB - BOE&#39;s chief economist turns hawkish; pound on the rise https://seekingalpha.com/news/3274720-boes-chief-economist-turns-hawkish-pound-on-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3274720-boes-chief-economist-turns-hawkish-pound-on-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274716\" data-ts=\"1498045663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274716-bofaml-downgrades-intel-on-amd-epyc-reveal-shares-down-1_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML downgrades Intel on AMD Epyc reveal; shares down 1.6%</a></h4><ul><li>        Bank of America Merrill Lynch downgrades Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) from Buy to Neutral and lowers the price target from $42 to $38 after yesterday&rsquo;s Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) Epyc server launch event.</li><li>               Analyst Vivek Arya lowers Intel&rsquo;s data center sales growth for FY18 from 11% to 8% and notes that AMD&rsquo;s Epyc has signed up Microsoft and Baidu among its big-name data center customers.&nbsp;</li><li>                  Meanwhile, Morgan Stanley rates AMD at Equal Weight with analyst Joseph Moore noting that AMD might have a price impact on Intel next year. Moore says Epyc launch impressive &ldquo;even as moderate skeptics.&rdquo;    </li><li>               Source: Bloomberg&nbsp;</li><li>               Intel shares are&nbsp;<font color='red'>down 1.55%&nbsp;</font>premarket. AMD shares are&nbsp;<font color='green'>up 5.22%</font>.&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274700-jefferies-reiterates-amd-buy-epyc-event-shares-2-percent\" target=\"_blank\">Jefferies reiterates on AMD Buy after Epyc event; shares up over 2%</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274716\" data-linked=\"BofAML downgrades Intel on AMD Epyc reveal; shares down 1.6%\" data-tweet=\"$INTC $INTC $AMD - BofAML downgrades Intel on AMD Epyc reveal; shares down 1.6% https://seekingalpha.com/news/3274716-bofaml-downgrades-intel-on-amd-epyc-reveal-shares-down-1_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3274716-bofaml-downgrades-intel-on-amd-epyc-reveal-shares-down-1_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>121&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274715\" data-ts=\"1498045622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YPF\" target=\"_blank\">YPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274715-argentine-adrs-rough-session-after-msci-decision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argentine ADRs could have rough session after MSCI decision</a></h4><ul><li>MSCI last night surprised <a href=\"https://seekingalpha.com/news/3274635-argentina-decision-delayed-saudi-arabia-moves-step-closer-emerging-market\" target=\"_blank\">by not upgrading </a>Argentina (NYSEARCA:<a href='https://seekingalpha.com/symbol/ARGT' title='Global X MSCI Argentina ETF'>ARGT</a>) to emerging market status - meaning its stocks will not be able to be added to emerging markets indices.</li><li>Probably the most popular of Argentine ADRs is <a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anonima'>YPF</a>, and it's&nbsp;<font color='red'>down 10%&nbsp;</font>premarket. BBVA Banco Frances (NYSE:<a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francs S.A.  ADR'>BFR</a>)&nbsp;<font color='red'>fell 7.6%</font>&nbsp;after hours. Cresud S.A. (NASDAQ:<a href='https://seekingalpha.com/symbol/CRESY' title='Cresud S.A.C.I.F. y A.'>CRESY</a>)&nbsp;<font color='red'>dropped 6.5%</font>. Grupo Financciero (NASDAQ:<a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a>)&nbsp;<font color='red'>-5.8%</font>; Pampa Energia (NYSE:<a href='https://seekingalpha.com/symbol/PAM' title='Pampa Energia S.A.'>PAM</a>)<font color='red'> -7%</font>.</li><li>Other ADRs of &nbsp;note: Banco Macro (NYSE:<a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a>), Grupo Supervielle (NYSE:<a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a>), Petrobas Argentina (NYSE:<a href='https://seekingalpha.com/symbol/PZE' title='Petrobras Argentina S.A.'>PZE</a>), Telecom Argentina (NYSE:<a href='https://seekingalpha.com/symbol/TEO' title='Telecom Argentina S.A.'>TEO</a>),&nbsp;Irsa Inversiones y Representaciones (NYSE:<a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a>), Tenaris (NYSE:<a href='https://seekingalpha.com/symbol/TS' title='Tenaris S.A.'>TS</a>), Ternium (NYSE:<a href='https://seekingalpha.com/symbol/TX' title='Ternium S.A.'>TX</a>),&nbsp;Transportadora de Gas del Sur (NYSE:<a href='https://seekingalpha.com/symbol/TGS' title='Transportadora de Gas del Sur'>TGS</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274715\" data-linked=\"Argentine ADRs could have rough session after MSCI decision\" data-tweet=\"$YPF $ARGT $YPF - Argentine ADRs could have rough session after MSCI decision https://seekingalpha.com/news/3274715-argentine-adrs-rough-session-after-msci-decision?source=tweet\" data-url=\"https://seekingalpha.com/news/3274715-argentine-adrs-rough-session-after-msci-decision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274712\" data-ts=\"1498045206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274712-talk-of-nike-selling-directly-on-amazon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talk of Nike selling directly on Amazon</a></h4><ul> <li>Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) may be close to selling products directly on Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>), according to Goldman Sachs' Lindsay Drucker Mann.</li> <li>The analyst believes the move would expand Nike's access to millennials through the fast-growing Amazon distribution channel.</li> <li>Keep an eye on Dick's Sporting Goods (NYSE:<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a>), Hibbett Sports (NASDAQ:<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a>), Foot Locker (NYSE:<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a>), and Finish Line (NASDAQ:<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a>) for volatility if the Nike-Amazon relationship expands.</li> <li>Source: Bloomberg</li> <li>Shares of Nike are <font color='green'>up 1.05%</font> premarket to $52.10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3274712\" data-linked=\"Talk of Nike selling directly on Amazon\" data-tweet=\"$NKE $NKE $AMZN - Talk of Nike selling directly on Amazon https://seekingalpha.com/news/3274712-talk-of-nike-selling-directly-on-amazon?source=tweet\" data-url=\"https://seekingalpha.com/news/3274712-talk-of-nike-selling-directly-on-amazon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274707\" data-ts=\"1498044850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274707-analysts-raise-adobe-systems-price-target-after-earnings-beat-shares-up-4_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Adobe Systems price target after earnings beat; shares up 4.7%</a></h4><ul><li>        Goldman Sachs <a href=\"https://www.streetinsider.com/Analyst+Comments/Adobe+%28ADBE%29+PT+Raised+to+%24147+at+Goldman+Sachs%2C+%22APRU+Continues+To+Drive+Upside%22/13030663.html\" target=\"_blank\">raises</a> Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) by $6 to $147 while reiterating a Neutral rating.</li><li>               Analyst Heather Bellini writes that the company unexpectedly increased FY17 revenue growth guidance and that she expects the company to meet EPS guidance.&nbsp;</li><li>               Piper Jaffray <a href=\"https://www.streetinsider.com/Analyst+Comments/Adobe+%28ADBE%29+PT+Raised+to+%24180+at+Piper+Jaffray/13030634.html\" target=\"_blank\">raises</a> its Adobe target by $20 to $180 while reiterating an Overweight rating.&nbsp;</li><li>               Analyst Alex Zukin cites accelerating yet sustainable business and geographic reporting trends while raising FY17 EPS estimate to $4.04 and FY18 EPS to $5.02.&nbsp;</li><li>                  Latest Adobe analyst standings: 12 Buy, 12 Outperform, 4 Hold, and 1 Sell.    </li><li>               Median price target: $145.&nbsp;</li><li>               Adobe shares are&nbsp;<font color='green'>up 4.71%&nbsp;</font>premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274619-adobe-q2-beats-estimates-shares-3_5-percent\" target=\"_blank\">Adobe Q2 beats estimates; shares up 3.5%</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274707\" data-linked=\"Analysts raise Adobe Systems price target after earnings beat; shares up 4.7%\" data-tweet=\"$ADBE - Analysts raise Adobe Systems price target after earnings beat; shares up 4.7% https://seekingalpha.com/news/3274707-analysts-raise-adobe-systems-price-target-after-earnings-beat-shares-up-4_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3274707-analysts-raise-adobe-systems-price-target-after-earnings-beat-shares-up-4_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274705\" data-ts=\"1498044770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYPL\" target=\"_blank\">PYPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274705-paypal-up-1_7-after-pac-crest-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PayPal up 1.7% after Pac Crest upgrade</a></h4><ul><li>PayPal's (NASDAQ:<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a>) \"Choice\" and Venmo strategies are about to move from the \"investment\" to the \"harvesting phase,\" says analyst Josh Beck, upgrading to Overweight. HIs $60 price target suggests&nbsp;<font color='green'>14% upside</font>.</li><li>Shares&nbsp;<font color='green'>+1.7%</font>&nbsp;premarket to $53.42.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274705\" data-linked=\"PayPal up 1.7% after Pac Crest upgrade\" data-tweet=\"$PYPL - PayPal up 1.7% after Pac Crest upgrade https://seekingalpha.com/news/3274705-paypal-up-1_7-after-pac-crest-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3274705-paypal-up-1_7-after-pac-crest-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274700\" data-ts=\"1498043912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274700-jefferies-reiterates-on-amd-buy-after-epyc-event-shares-up-over-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies reiterates on AMD Buy after Epyc event; shares up over 2%</a></h4><ul><li>           Jefferies <a href=\"https://www.streetinsider.com/Analyst+Comments/AMD+%28AMD%29+EPYC+Launches+with+Some+Big-Name+Customers%2C+Jefferies+Notes%3B+Sees+EPYC+Capturing+7%25+of+Market+by+End+of+2018/13030666.html\" target=\"_blank\">reiterates</a> Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) at a Buy rating with $16 price target following yesterday afternoon&rsquo;s launch event for new Zen MPU Epyc. </li><li> Analyst Mark Lipacis discusses the key reveals during the event including the fact that Baidu, Microsoft Azure, Dropbox, and Bloomberg all plan to put Epyc in their data centers. </li><li>           Dell EMC, SuperMicro, and HP all announced Epyc-based SKUs. </li><li>        Lipacis expects Epyc to capture 7% of the total server market by the end of next year.</li><li>               Source: <a href=\"https://www.streetinsider.com/Analyst+Comments/AMD+%28AMD%29+EPYC+Launches+with+Some+Big-Name+Customers%2C+Jefferies+Notes%3B+Sees+EPYC+Capturing+7%25+of+Market+by+End+of+2018/13030666.html\" target=\"_blank\">StreetInsider</a>&nbsp;</li><li>               Latest AMD analyst standings: 5 Buy, 5 Outperform, 17 Hold, 2 Underperform, and 2 Sell.&nbsp;</li><li>               Median price target: $12.50.&nbsp;</li><li>               AMD shares are&nbsp;<font color='green'>up 2.06%&nbsp;</font>premarket to $12.90 after closing yesterday&nbsp;<font color='green'>up nearly 6%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3274700\" data-linked=\"Jefferies reiterates on AMD Buy after Epyc event; shares up over 2%\" data-tweet=\"$AMD - Jefferies reiterates on AMD Buy after Epyc event; shares up over 2% https://seekingalpha.com/news/3274700-jefferies-reiterates-on-amd-buy-after-epyc-event-shares-up-over-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3274700-jefferies-reiterates-on-amd-buy-after-epyc-event-shares-up-over-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274697\" data-ts=\"1498043600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274697-immunocellular-suspends-patient-randomization-in-late-stage-study-of-ictminus-107-due-to-lack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoCellular suspends patient randomization in late-stage study of ICT-107 due to lack of money</a></h4><ul><li>Thinly traded nano cap ImmunoCellular Therapeutics (<a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a>) is poised for a down day today after it <a href=\"https://seekingalpha.com/pr/16867683-immunocellular-therapeutics-provides-update-strategic-review-decision-suspend-patient\" target=\"_blank\">announced </a>that it has suspended patient randomization in its <a href=\"https://clinicaltrials.gov/ct2/show/NCT02546102?term=ict-107&amp;phase=2&amp;rank=1\" target=\"_blank\">Phase 3 clinical trial</a> assessing lead product candidate <a href=\"http://www.imuc.com/pipeline/ict-107\" target=\"_blank\">ICT-107</a> for the treatment of newly diagnosed glioblastoma due to insufficient financial resources.</li><li>The company says that it will continue evaluate/explore strategic alternatives including a merger, reorganization or other business combination.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3267872-immunocellular-20-percent-money-woes\" target=\"_blank\">ImmunoCellular down 20% on money woes</a> (May 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3274697\" data-linked=\"ImmunoCellular suspends patient randomization in late-stage study of ICT-107 due to lack of money\" data-tweet=\"$IMUC - ImmunoCellular suspends patient randomization in late-stage study of ICT-107 due to lack of money https://seekingalpha.com/news/3274697-immunocellular-suspends-patient-randomization-in-late-stage-study-of-ictminus-107-due-to-lack?source=tweet\" data-url=\"https://seekingalpha.com/news/3274697-immunocellular-suspends-patient-randomization-in-late-stage-study-of-ictminus-107-due-to-lack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3274692\" data-ts=\"1498042454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXS\" target=\"_blank\">AVXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3274692-avexis-prices-stock-offering-65_60-8-below-yesterdays-close-of-71_10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AveXis prices stock offering at $65.60, 8% below yesterday&#39;s close of $71.10</a></h4><ul><li>AveXis (NASDAQ:<a href='https://seekingalpha.com/symbol/AVXS' title='AveXis'>AVXS</a>) <a href=\"https://seekingalpha.com/pr/16867563-avexis-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 3.575M shares of common stock at $65.60 which should yield gross proceeds of ~$234.5M. Underwriters over-allotment is an additional 536,250 shares. Closing date is June 26.</li><li>Net proceeds will fund R&amp;D, clinical trials, working capital and general corporate purposes.</li><li>Yesterday's close was $71.10. Shares are unchanged premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3274692\" data-linked=\"AveXis prices stock offering at $65.60, 8% below yesterday&#39;s close of $71.10\" data-tweet=\"$AVXS - AveXis prices stock offering at $65.60, 8% below yesterday&#39;s close of $71.10 https://seekingalpha.com/news/3274692-avexis-prices-stock-offering-65_60-8-below-yesterdays-close-of-71_10?source=tweet\" data-url=\"https://seekingalpha.com/news/3274692-avexis-prices-stock-offering-65_60-8-below-yesterdays-close-of-71_10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":62,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}